CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Legal Officer acquired 10,000 shares (grant or award)
- 4 Grant or award SVP, People and Culture acquired 42,800 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 28,000 shares (grant or award)
- 4 Grant or award Chief Business & Strategy Ofcr acquired 28,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 27,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 25,450 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 26,750 shares (grant or award)
Page 5 of 13 · 248 filings